Changes this week
Changes detected in the 7 days to Nov 21, 2026
- Notable: Virtual Reality-based Rehabilitation for Traumatic Hand and Wrist Injuries Primary endpoint(s) modified
- Notable: Photobiomodulation for Reducing Sedative-Hypnotic Use:Clinical Trial of a Light-Therapy Device Enrollment increased: 60 → 90 participants
- Notable: Citicoline Eye Drops 2% on Visual Field Preservation · Open Angle Glaucoma Primary and study completion dates pushed to Jul 1, 2029
- Notable: Zasocitinib in Children and Teenagers With Plaque Psoriasis Primary and study completion pushed from Jan 24, 2033 to Jul 3, 2034
- Notable: TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone · Recurrent Glioblastoma Primary completion pushed from Jul 2027 to Jul 2028
- Notable: Patients With Primary Vitreoretinal Lymphoma Primary and study completion pushed from Dec 2026 to Dec 2029
- Notable: Trials of Benmelstobart Injection Combined With Anlotinib Hydrochloride Capsules · Advanced or Unresectable Alveolar Soft Part Sarcoma Primary completion pushed from Nov 2027 to Dec 2028
- Notable: OPT101 · Type 1 Diabetes Mellitus Primary completion pushed from May 31, 2026 to May 31, 2027
- Notable: Intrathecally Administered Gene Therapy AMT-162 · SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS) Primary completion pushed from Sep 30, 2026 to Dec 30, 2030
- Notable: Relacorilant in Combination With Different Treatment Regimens · Gynecological Cancers Primary completion pushed from Aug 2026 to Dec 2027
- Notable: NHWD-870 HCl in Adults and · Advanced NUT Cancer Primary completion pushed from Jun 30, 2025 to Mar 30, 2027
- Notable: Ablation of Arteries · Type 2 Diabetes Mellitus and Its Comorbidities Primary completion pushed from Jan 2025 to Jun 2027
- Notable: Arterial Ablation · Type 2 Diabetes Mellitus and Its Comorbidities Primary completion pushed from Jan 2025 to May 2027
- Notable: Usability of the EXPLORER Exoskeleton · Neurodevelopmental Disorders in Natural Environments Primary completion pushed from Apr 1, 2025 to Aug 1, 2026
- Notable: Lubricin-inspired Osteoarthritis Treatment: a Unique Solution Primary completion pushed from Jun 2027 to Mar 2028
- Notable: Juläine (TM) · Atrophic Facial Acne Scars Primary completion pushed from Dec 2026 to Jan 2028
- Notable: Acellular Dermal Matrix Investigation in Breast Reconstruction Primary completion pushed from Dec 2026 to Dec 2027
- Notable: Novel Joint Distraction Knee Orthosis for Treating Medial Knee Osteoarthritis Primary completion pushed from Jun 1, 2026 to Sep 1, 2027
- Notable: HEARTFELT Study Primary completion pushed from Jan 1, 2028 to Dec 31, 2028
- Notable: Juläine™ in Improving Gluteal Skin Laxity in Adults Primary completion pushed from Apr 2027 to Jan 2028
- Notable: AccuraSee™ IOPCL for Secondary Implantation in the Capsular Bag to Improve Near and/or Intermediate Vision Following Previous Cataract Surgery Primary and study completion pushed from Mar 2026 to Dec 2027
- Notable: PGx Medication Safety Reviews · IDD Primary completion pushed from Jul 31, 2027 to Jul 31, 2028
- Notable: Multicentric Pilot Study for the Application of an Endourethral Device · Stress Urinary Incontinence Primary and study completion pushed from Dec 31, 2026 to Jun 30, 2027
- Notable: Imatinib to Increase RUNX1 Activity · Germline RUNX1 Deficiency Primary completion pushed from Oct 30, 2026 to Oct 30, 2027
- Notable: Reduced Port Laparoscopic Gastrectomy for Gastric Cancer Primary and study completion pushed from Mar 1, 2027 to Mar 1, 2029
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates